This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Lesser, Glenn
| Item Type | Name |
|
Academic Article
|
Phase I clinical and pharmacokinetic study of irinotecan in adults with recurrent malignant glioma.
|
|
Academic Article
|
Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: final report of NABTT 97-11.
|
|
Academic Article
|
Phase I and pharmacokinetic study of karenitecin in patients with recurrent malignant gliomas.
|
|
Academic Article
|
A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas.
|
|
Academic Article
|
A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306).
|
|
Academic Article
|
Phase II study of Ginkgo biloba in irradiated brain tumor patients: effect on cognitive function, quality of life, and mood.
|
|
Academic Article
|
Suramin and radiotherapy in newly diagnosed glioblastoma: phase 2 NABTT CNS Consortium study.
|
|
Academic Article
|
Phase I study of lenalidomide in solid tumors.
|
|
Academic Article
|
A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy.
|
|
Academic Article
|
Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant glioma.
|
|
Academic Article
|
Phase II preradiation R115777 (tipifarnib) in newly diagnosed GBM with residual enhancing disease.
|
|
Academic Article
|
Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma.
|
|
Academic Article
|
A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma.
|
|
Academic Article
|
A phase I dose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiforme.
|
|
Academic Article
|
A phase II trial of thalidomide and procarbazine in adult patients with recurrent or progressive malignant gliomas.
|
|
Academic Article
|
Phase 2 study of dose-intense temozolomide in recurrent glioblastoma.
|
|
Academic Article
|
Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas.
|
|
Academic Article
|
Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.
|
|
Academic Article
|
Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424.
|
|
Academic Article
|
Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue.
|
|
Academic Article
|
Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-ß tyrosine kinase inhibitor, in patients with recurrent glioblastoma.
|
|
Grant
|
Evaluation of AZD9291 in Glioblastoma patients with activated EGFR
|
|
Grant
|
New Approaches to Brain Tumor Therapy, NABTT CNS
|
|
Academic Article
|
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02.
|
|
Academic Article
|
Safety of pioglitazone during and after radiation therapy in patients with brain tumors: a phase I clinical trial.
|
|
Academic Article
|
A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma.
|
|
Academic Article
|
A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma.
|
|
Academic Article
|
Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424.
|